Results for
"[search-keyword]"
Sponsor content
142 result(s) found, displaying 1 to 10
- AusPAR: LumakrasAustralian Public Assessment Report (AusPAR)AusPAR for Lumakras (sotorasib) for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) who have received at least one prior systemic therapy for advanced disease.
- KYPROLIS (Amgen Australia Pty Ltd)Prescription medicine registrationActive ingredients: carfilzomib.
- LumakrasPrescription medicine decision summaryTGA Decision: Lumakras (sotorasib) is approved to treat adult patients with non-small cell lung cancer (NSCLC).
- LUMAKRAS sotorasib 120 mg tablet blister pack (353210)ARTGAustralian Register of Therapeutic Goods (ARTG) information for LUMAKRAS sotorasib 120 mg tablet blister pack.
- LUMAKRAS (Amgen Australia Pty Ltd)Prescription medicine registrationActive ingredients: sotorasib.
- Amgen Australia Pty Ltd - Subcutaneous/intramuscular injection set, medicated (385655)ARTGAustralian Register of Therapeutic Goods (ARTG) information for Amgen Australia Pty Ltd - Subcutaneous/intramuscular injection set, medicated.
- NPLATE (Amgen Australia Pty Ltd)Prescription medicine registrationActive ingredients: romiplostim.
- KYPROLIS Amgen Australia Pty LtdAug-2021Prescription medicine evaluationActive ingredient: carfilzomib.